Literature DB >> 17192335

Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry.

Xilin Yang1, Wing-Yee So, Alice P S Kong, Chung-Shun Ho, Christopher W K Lam, Richard J Stevens, Ramon R Lyu, Donald D Yin, Clive S Cockram, Peter C Y Tong, Vivian Wong, Juliana C N Chan.   

Abstract

OBJECTIVE: We sought to develop stroke risk equations for Chinese patients with type 2 diabetes in Hong Kong. RESEARCH DESIGN AND METHODS: A total of 7,209 Hong Kong Chinese type 2 diabetic patients without a history of stroke at baseline were analyzed. The data were randomly and evenly divided into the training subsample and the test subsample. In the training subsample, stepwise Cox models were used to develop the risk equation. Validation of the U.K. Prospective Diabetes Study (UKPDS) stroke risk engine and the current stroke equation was performed in the test dataset. The life-table method was used to check calibration, and the area under the receiver operating characteristic curve (aROC) was used to check discrimination.
RESULTS: A total of 372 patients developed incident stroke during a median of 5.37 years (interquartile range 2.88-7.78) of follow-up. Age, A1C, spot urine albumin-to-creatinine ratio (ACR), and history of coronary heart disease (CHD) were independent predictors. The performance of the UKPDS stroke engine was suboptimal in our cohort. The newly developed risk equation defined by these four predictors had adequate performance in the test subsample. The predicted stroke-free probability by the current equation was within the 95% CI of the observed probability. The aROC was 0.77 for predicting stroke within 5 years. The risk score was computed as follows: 0.0634 x age (years) + 0.0897 x A1C + 0.5314 x log(10) (ACR) (mg/mmol) + 0.5636 x history of CHD (1 if yes). The 5-year stroke probability can be calculated by: 1 - 0.9707(EXP (Risk Score - 4.5674)).
CONCLUSIONS: Although the risk equation performed reasonably well in Chinese type 2 diabetic patients, external validation is required in other populations.

Entities:  

Mesh:

Year:  2007        PMID: 17192335     DOI: 10.2337/dc06-1273

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  39 in total

1.  Diabetes, insulin and cancer risk.

Authors:  Xi-Lin Yang; Juliana Cn Chan
Journal:  World J Diabetes       Date:  2012-04-15

2.  Refitting of the UKPDS 68 risk equations to contemporary routine clinical practice data in the UK.

Authors:  P McEwan; H Bennett; T Ward; K Bergenheim
Journal:  Pharmacoeconomics       Date:  2015-02       Impact factor: 4.981

Review 3.  Toward Big Data Analytics: Review of Predictive Models in Management of Diabetes and Its Complications.

Authors:  Simon Lebech Cichosz; Mette Dencker Johansen; Ole Hejlesen
Journal:  J Diabetes Sci Technol       Date:  2015-10-14

4.  Cost-effectiveness of a primary care multidisciplinary Risk Assessment and Management Program for patients with diabetes mellitus (RAMP-DM) over lifetime.

Authors:  Fangfang Jiao; Eric Yuk Fai Wan; Colman Siu Cheung Fung; Anca Ka Chun Chan; Sarah Morag McGhee; Ruby Lai Ping Kwok; Cindy Lo Kuen Lam
Journal:  Endocrine       Date:  2018-08-28       Impact factor: 3.633

5.  From design to implementation--the Joint Asia Diabetes Evaluation (JADE) program: a descriptive report of an electronic web-based diabetes management program.

Authors:  Gary T Ko; Wing-Yee So; Peter C Tong; Francois Le Coguiec; Debborah Kerr; Greg Lyubomirsky; Beaver Tamesis; Troels Wolthers; Jennifer Nan; Juliana Chan
Journal:  BMC Med Inform Decis Mak       Date:  2010-05-13       Impact factor: 2.796

6.  Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes: the new zealand diabetes cohort study.

Authors:  C Raina Elley; Elizabeth Robinson; Tim Kenealy; Dale Bramley; Paul L Drury
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 17.152

Review 7.  Diabetes and its comorbidities--where East meets West.

Authors:  Alice P S Kong; Gang Xu; Nicola Brown; Wing-Yee So; Ronald C W Ma; Juliana C N Chan
Journal:  Nat Rev Endocrinol       Date:  2013-05-28       Impact factor: 43.330

8.  Effect of interactions between C peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitus.

Authors:  Gary T C Ko; Wing-Yee So; Peter C Tong; Wing-Bun Chan; Xilin Yang; Ronald C Ma; Alice P Kong; Risa Ozaki; Chun-Yip Yeung; Chun-Chung Chow; Juliana C Chan
Journal:  CMAJ       Date:  2009-04-28       Impact factor: 8.262

9.  Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus.

Authors:  Xilin Yang; WingYee So; Gary T C Ko; Ronald C W Ma; Alice P S Kong; Chun-Chung Chow; Peter C Y Tong; Juliana C N Chan
Journal:  CMAJ       Date:  2008-08-26       Impact factor: 8.262

Review 10.  Cardiovascular risk assessment scores for people with diabetes: a systematic review.

Authors:  P Chamnan; R K Simmons; S J Sharp; S J Griffin; N J Wareham
Journal:  Diabetologia       Date:  2009-07-24       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.